» Articles » PMID: 10232583

Centrosomal Kinase AIK1 is Overexpressed in Invasive Ductal Carcinoma of the Breast

Overview
Journal Cancer Res
Specialty Oncology
Date 1999 May 8
PMID 10232583
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

A centrosomal serine/threonine kinase, AIK1(3)/breast tumor amplified kinase/aurora2, which was recently identified as an oncogene, shows high amino acid identity with chromosome segregation kinases, fly Aurora, and yeast Ipl1. Immunohistochemical analyses of invasive ductal adenocarcinomas of the breast revealed that overexpression of AIK1 was observed in 94% of the cases, irrespective of the histopathological type, whereas the protein was not detected in normal ductal and lobular cells. Benign breast lesions including fibrocystic disease and fibroadenoma (epithelial components) displayed weakly detectable AIK1 expression in part of the lesions. This is the first immunohistochemical report of AIK1 expression in primary human breast carcinomas. Although the physiological function(s) of AIK1 kinase during cell division remains to be determined, the markedly high positivity of AIK1 staining in the cancer lesions suggested a possible involvement of its overexpression in the tumorigenesis of some of breast cancer cells.

Citing Articles

A Temporal PROTAC Cocktail-Mediated Sequential Degradation of AURKA Abrogates Acute Myeloid Leukemia Stem Cells.

Liu F, Wang X, Duan J, Hou Z, Wu Z, Liu L Adv Sci (Weinh). 2022; 9(22):e2104823.

PMID: 35652200 PMC: 9353462. DOI: 10.1002/advs.202104823.


Screening for Inhibitors of YAP Nuclear Localization Identifies Aurora Kinase A as a Modulator of Lung Fibrosis.

Yang Y, Santos D, Pantano L, Knipe R, Abe E, Logue A Am J Respir Cell Mol Biol. 2022; 67(1):36-49.

PMID: 35377835 PMC: 9798384. DOI: 10.1165/rcmb.2021-0428OC.


Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression.

Yoo S, Sinha A, Yang D, Altorki N, Tandon R, Wang W Nat Commun. 2022; 13(1):1592.

PMID: 35332150 PMC: 8948234. DOI: 10.1038/s41467-022-29230-7.


Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal Müllerian epithelium and benign, borderline and malignant serous ovarian neoplasms.

Alkhateeb K, Crane J, Sak M, Jorgensen C, ODonnell J, Zumbar C Diagn Pathol. 2021; 16(1):98.

PMID: 34706741 PMC: 8549328. DOI: 10.1186/s13000-021-01158-4.


The impact of Aurora kinase A genetic polymorphisms on cervical cancer progression and clinicopathologic characteristics.

Wu P, Wang C, Hsieh M, Lee C, Wang P, Lin C Int J Med Sci. 2021; 18(11):2457-2465.

PMID: 33967624 PMC: 8100634. DOI: 10.7150/ijms.58516.